Highmark Interactive Announces Collaboration with Mayo Clinic to Assess Impact of 'Long COVID' on Cognitive Function

Ontario Industry Updates
Written By Viktoriya Shabat
a6e5b85b-fbe4-4f92-a238-404228b0b686.png

BrainFx, a wholly owned subsidiary of Highmark Interactive, announced on October 5, its collaboration with Mayo Clinicto launch a COVID-19 Cognitive Recovery Tracker to better understand and assess the impact of “Long COVID” or “Post-COVID-19 Syndrome” on cognitive function over time.

Viktoriya Shabat
Previous

Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel TCR-Based T Cell Therapy Company and TIO Bioventures Portfolio Company
Next

Boston Scientific Announces Agreement to Acquire Baylis Medical Company Inc.